Taiwan’s new cabinet-level Ministry of Sports marks a shift in how the government views athletics, linking participation, diplomacy, and industry development. The challenge now lies in turning Olympic success and public enthusiasm into lasting policy influence.
An investigation into Taiwan’s tap water uncovers a story that goes far beyond lab results. While municipal systems, especially in Taipei, meet world-class standards, trust erodes along the way through aging pipes, rooftop tanks, uneven governance, and decades of inherited caution.
Taiwan’s fight against antimicrobial resistance is entering a new phase as Taiwan CDC and Pfizer formalize a public-private partnership to strengthen surveillance, research, and public education. The new MOU underscores the urgency of AMR and aligns with Taiwan’s expanding One Health strategy.
Taiwan is placing vaccination at the heart of its Healthy Taiwan agenda, treating prevention as essential to easing pressure on the healthcare system.
Taiwan’s rising breast cancer mortality reflects gaps in early detection, complete treatment, and timely access to new therapies. Strengthening personalized screening and data-driven care policies is key to improving outcomes.
As Taiwan advances its Healthy Taiwan vision, experts from government, academia, and industry underscored that sustained investment in vaccination is essential to protecting vulnerable populations and strengthening long-term healthcare resilience.
Amid a worsening nursing shortage, Taiwan’s hospitals are adopting innovative care models and AI tools to ease workloads and improve patient outcomes. From KMUH’s Enhanced Recovery After Surgery protocol to TCVGH’s Nurabot, smarter workflows are cutting hospital stays and boosting satisfaction though experts warn lasting change requires systemic reform.
AmCham Taiwan’s 2025 Cancer Summit gathered leaders from government, industry, academia, and civil society to advance innovation and policy in cancer care. Discussions centered on early detection, sustainable funding for the Cancer Drugs Fund, and aligning with global standards to meet Taiwan’s 2030 goal of reducing cancer mortality by one-third.
As Taiwan transitions into a super-aged society, addressing chronic disease management and healthcare sustainability has become a national priority. At the 2025 Healthy Aging Forum, government and industry leaders explored strategies to enhance preventive care, digital health solutions, and public-private partnerships to improve long-term health outcomes for Taiwan’s aging population.
The 2024 U.S.-Taiwan Patient Care Innovation Forum, co-hosted by AmCham Taiwan and AIT, showcased significant advancements in healthcare technology, including expanded hemodialysis, IMVAD for heart failure, and precision radioligand therapy. Keynote speakers emphasized the need for evolving policies to support these innovations and align with Taiwan’s healthcare goals.
